Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04125212
Other study ID # WeiHuang
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date September 21, 2019
Est. completion date June 1, 2022

Study information

Verified date September 2021
Source Peking University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To investigate the effects of air pollution on surrogate cardio-metabolic outcomes in young healthy adults.


Description:

To investigate the effects of air pollution on surrogate cardio-metabolic outcomes in a panel study involving young healthy adults living in Beijing, China with extreme high ambient air pollution levels.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 160
Est. completion date June 1, 2022
Est. primary completion date January 16, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: 1. Living in Peking University Health Science Center neighborhood. 2. Non smoker and no diseases. Exclusion Criteria: 1. Advanced microvascular complications and active cardiovascular disease. 2. Pregnancy or intent to get pregnant during the study period.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Peking University ,School of Public Health Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure Systolic blood pressure and diastolic blood pressure Four months
Secondary Systemic inflammatory Systemic inflammation biomarkers, such as C-reactive protein etc. Four months
See also
  Status Clinical Trial Phase
Completed NCT02601352 - Air Pollution and Cardiometabolic Study
Completed NCT01921010 - Benefit of Elevation of HDL-C in Women Phase 4
Recruiting NCT03206593 - Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure N/A
Withdrawn NCT02058875 - Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring Phase 4
Completed NCT03899675 - Impact of Caffeine Intake on Autonomic Parameters in the Exercise of Strength N/A